A Boston-based Harvard Medical School study found oncologists unsure how to handle artificial intelligence if it presents a treatment plan they would not recommend.
The Latest
CAR-T therapy is becoming a more frequent treatment for Medicare patients with diffuse large B-cell lymphoma, but changes in CAR-T treatments that push it as an earlier line of therapy may change where patients receive the therapy — and ultimately,…
The blood pressure drug Losartan may be able to block a gene found in the blood, angiotensin II receptor type 1 (AGTR1), and improve the effectiveness of chemotherapy, according to a study published June 19 in Science Translational Medicine.
Cancer deaths are down over the past three decades, but cancerphobia is as strong as ever, Washington Post columnist Steven Petrow reported July 5.
The FDA has ordered Miami-based North Shore Medical Center to halt mammogram services over quality issues that may have led to inaccurate results, according to a letter obtained by the Miami Herald.
Hannibal (Mo.) Regional Healthcare System has received $15 million in state funds to expand services and build a new cancer center in Kirksville, Mo., it announced July 2.
At The University of Texas MD Anderson Cancer Center, research and patient care are inextricably linked. Our approach to research-driven patient care involves using the latest clinical findings and advances to inform how we provide care and facilitate optimal patient…
Patients diagnosed with certain abdominal cancers at Charleston, S.C.-based MUSC Hollings Cancer Center can now get next-day access to follow-up care, the system announced July 2.
Researchers at Tampa-based University of South Florida and Bloomington-based Indiana University found cisplatin is linked to increased hearing loss.
There are more than 18 million cancer survivors living in the U.S., but few primary care providers know how to care for this patient group. To close the gap, Houston-based the University of Texas MD Anderson Cancer Center is launching…